Stay updated with breaking news from Christopher velis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Noveome and Neuronascent Each Receive Rare Pediatric Disease Designations globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
BOA™ Biomedical's GARNET™ Therapeutic Demonstrates Safety Endpoint and Promising Results During Initial First in Human Use prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Noveome Biotherapeutics, Inc. Commences Phase 1 Clinical Study of ST266 Application for Infectious Disease (including COVID-19) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
400+ Investors, Innovators and Strategics Confirmed For LSI 2021 Emerging Medtech Summit in Southern California New Dates, May 11-13, Virtual Options and Keynote Speakers Announced News provided by Share this article Share this article LOS ANGELES, Jan. 25, 2021 /PRNewswire/ Life Science Intelligence (LSI) announced today that more than 400 innovators, strategics and investors have registered for the Emerging Medtech Summit, which will be held May 11-13, at The Ritz-Carlton, Laguna Niguel Hotel in the beachside community of Dana Point in Southern California. Key speakers have also been announced, including Paul LaViolette, Managing Partner, SV Health Investors, Scott Huennekens, Executive Chairman, Acutus and Christopher Velis, Founder & Executive Chairman, Miraki Innovation. ....